A Real-World Study Analyzing Efficacy and Safety of Nivolumab in Advance Squamous Cell Oesophageal Cancer
Latest Information Update: 13 Dec 2022
At a glance
- Drugs Nivolumab (Primary)
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 13 Dec 2022 New trial record
- 09 Nov 2022 Results presented at the 25th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research